Litcius/Paper detail

p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss

Shicheng Huo, Xuesong Liu, Shutao Zhang, Zhuocheng Lyu, Jue Zhang, You Wang, Bin’en Nie, Bing Yue

2021International Immunopharmacology18 citationsDOI

Topics & Concepts

OsteoclastRANKLOsteoporosisEndocrinologyInternal medicineChemistryBone resorptionCancer researchBone mineralMAPK/ERK pathwayMedicineCell biologyPharmacologySignal transductionBiologyBiochemistryReceptorActivator (genetics)Bone Metabolism and DiseasesBone health and treatmentsBone health and osteoporosis research
p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss | Litcius